1
Spanish Participants Information details and publications
Dr. José Eustasio Meca Lallana
Chief of Service of Unit Multiple Sclerosis at the Hospital Arrixaca in MurciaSpain.
Directorof the Neurology Department.
Recent Publications:
-Meca-Lallana JE, Balseiro JJ, Lacruz F, Guijarro C, Sanchez O, Cano A,
Costa-Frossard L, Hernández-Clares R, Sanchez-de la Rosa R; Escala Study Group.
Spasticity improvement in patients with relapsing-remitting multiple sclerosis
switching from interferon-β to glatiramer acetate: the Escala Study. J Neurol
Sci. 2012 Apr 15;315(1-2):123-8. doi: 10.1016/j.jns.2011.11.010. Epub 2011 Nov
30. PubMed PMID: 22133480.
-Meca-Lallana JE, de Mingo-Casado P, Amorin-Díaz M, Martínez-Navarro ML,
Barreiro AF. Effects of glatiramer acetate on spasticity in previously
interferon-beta-treated and treatment-naive patients with relapsing-remitting
multiple sclerosis: a prospective, nonrandomized, open-label, uncontrolled,
observational pilot study. Clin Ther. 2010 Jun;32(6):1061-6. doi:
10.1016/j.clinthera.2010.06.005. PubMed PMID: 20637960.
Dr. José María Prieto González
Vocal Member of the Spànish Neurologist Society. Neurologist from the Hospital Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela.
Recent Publications:
-Munteanu CR, Fernández-Blanco E, Seoane JA, Izquierdo-Novo P,
Rodríguez-Fernández JA, Prieto-González JM, Rabuñal JR, Pazos A. Drug discovery
and design for complex diseases through QSAR computational methods. Curr Pharm
Des. 2010;16(24):2640-55. Review. PubMed PMID: 20642425.
-Prieto González JM, Lema Bouzas M, Dapena Bolaño MD. [Multiple sclerosis:
diagnosis and treatment]. Med Clin (Barc). 2004 Nov 27;123(19):743-8. Review.
Spanish. PubMed PMID: 15574290.
Dr. Javier Olascoaga Urtaza
Cooridinator from Multiple Sclerosis Unit and Responsabile of Clinic Investigation
at the University Hospital in Donostia, Bilbao.
Dra. Yolanda Aladro Benito
Consultant at the Hospital Universitario Getafe, Madrid, Spain.
Publications:
-Duque P, Ibanez J, Del Barco A, Sepulcre J, de Ramon E, Fernandez-Fernandez O;
grupo de estudio de la Batería Neuropsicológica Breve en la Esclerosis Múltiple
(BNBEM. [Normalisation and validation of the Brief Neuropsychological Battery as
the reference neuropsychological test in multiple sclerosis]. Rev Neurol. 2012
Mar 1;54(5):263-70. Spanish. PubMed PMID: 22362474.
-Cerezo García M, Martín Plasencia P, Aladro Benito Y, Balseiro Gómez JJ, Rueda
Marcos A. Executive function and memory in patients with relapsing-remitting
multiple sclerosis. Psicothema. 2009 Aug;21(3):416-20. PubMed PMID: 19622322.
Dra. Cristina Iñiguez Martínez
Consultant Neurologists at Neurology Service from the Universitary Clinic Hospital Lozano-Blesa in Zarazoza
Publications:
-Larrode-Pellicer P, Alberti-González O, Iñiguez-Martínez C, Santos Lasaosa S,
Pérez-Lázaro C, López del Val LJ. [Pronostic factors and survival in motor neuron
disease]. Neurologia. 2007 Jul-Aug;22(6):362-7. Spanish. PubMed PMID: 17610164.
-Fleta Zaragozano J, Iñiguez Martínez C, Pina Leita JI, Bueno Sánchez M. [The
value of magnetic resonance in the diagnosis of multiple sclerosis in childhood.
A report of a case]. An Esp Pediatr. 1999 Aug;51(2):211-2. Spanish. PubMed PMID:
10495519.
Dra. Carmen Calles
Neurologist Coordinator of the Multiple Sclerosis University Hospital Son Espases, Palma de Mallorca, Spain.
Dra. Dulce María Solar
Chief of Service from Neurology Unit at the Cabueñes Hospital ,Gijón, Spain.
Publications:
-Meca-Lallana JE, Balseiro JJ, Lacruz F, Guijarro C, Sanchez O, Cano A,
Costa-Frossard L, Hernández-Clares R, Sanchez-de la Rosa R; Escala Study Group.
Spasticity improvement in patients with relapsing-remitting multiple sclerosis
switching from interferon-β to glatiramer acetate: the Escala Study. J Neurol
Sci. 2012 Apr 15;315(1-2):123-8. doi: 10.1016/j.jns.2011.11.010. Epub 2011 Nov
30. PubMed PMID: 22133480.
- Sastre-Garriga J, Rovira A, Bonaventura I, Escudero-Torrella J, Marco-Igual M,
Aymerich X, de Andres C, Lacruz F, Escartin A, Olascoaga J, Solar D, Farres J,
Arroyo-Gonzalez R, Montalban X, En Nombre Del Grupo de Investigadores Del Estudio
Prem EN. [Spanish multi-centre observational study of the first attacks
suggestive of multiple sclerosis: the PREM cohort]. Rev Neurol. 2011 Nov
16;53(10):577-83. Spanish. PubMed PMID: 22052172.
Dr. Dionisio Fernández Uría
Chief of Service of N>eurology Service at Hospital de Cabueñes, Gijón, Spain.
-Fernández Uría D. [Treatment of multiple sclerosis]. Neurologia. 1999 Dec;14
Suppl 6:1-12. Review. Spanish. PubMed PMID: 10659600.
Dra. Maria Luisa Martinez Ginés
Consultant Neurologist at Gregorio Marañon Hospital in Madrid, Spain.
-Aristimuño C, de Andrés C, Bartolomé M, de las Heras V, Martínez-Ginés ML,
Arroyo R, Fernández-Cruz E, Sánchez-Ramón S. IFNbeta-1a therapy for multiple
sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: a
longitudinal 1-year study. Clin Immunol. 2010 Feb;134(2):148-57. doi:
10.1016/j.clim.2009.09.008. Epub 2009 Nov 8. PubMed PMID: 19900844.
-de Andrés C, Aristimuño C, Bartolomé M, de Las Heras V, Martínez-Ginés ML,
Arroyo R, Fernández-Cruz E, Sánchez-Ramón S. Clinical response to
interferon-beta-1a may be linked to low baseline circulating BDCA1 myeloid
dendritic cells Differential role of circulating dendritic cells and CD4+
regulatory T-cells in relapsing-remitting multiple sclerosis: a 1-year
longitudinal study. J Neuroimmunol. 2009 Jul 25;212(1-2):112-20. doi:
10.1016/j.jneuroim.2009.04.009. Epub 2009 May 15. PubMed PMID: 19446889.
1